CBC Group and GHO Capital Create World's Largest Healthcare Investment Manager in US$21B Merger

The Quick Take

• Singapore-based CBC Group and London's GHO Capital merge to create the world's largest dedicated healthcare investment manager with US$21 billion in assets
• The combined entity positions healthcare as the sector least affected by geopolitical tensions, according to both firms' leadership
• The merger brings together CBC Group's Asia-Pacific healthcare focus with GHO Capital's European expertise in a single global platform

CBC Group of Singapore and GHO Capital of London have completed a US$21 billion merger that creates the world's largest dedicated healthcare-focused investment manager. The deal combines CBC Group's dominant position in Asia-Pacific private healthcare assets with GHO Capital's deep European portfolio expertise, spanning pharmaceutical services, medical devices, and healthcare infrastructure. The scale of the combined entity — the largest of its kind globally — reflects a broader institutional conviction that healthcare remains a structurally defensive sector with compounding demand growth across both developed and emerging markets.

The creation of a US$21 billion healthcare investment platform has clear capital-flow implications for the sector. Large dedicated managers attract a disproportionate share of institutional capital, particularly from sovereign wealth funds and pension allocators seeking defensive growth assets. Smaller healthcare-focused private equity rivals in Asia — including KKR's Asia health unit and Temasek's life sciences arm — will face increased competition for prime deal access. The merger also accelerates deal velocity in Southeast Asian private healthcare infrastructure, where CBC Group has historically been a dominant allocator.

The forward signal to watch is how the combined entity deploys capital: whether it prioritizes ASEAN hospital network acquisitions, European pharmaceutical services consolidation, or emerging-market health infrastructure. The macro variable is healthcare regulatory policy across key markets — any pricing controls or reimbursement rate changes in India, China, or Europe could alter return profiles for the merged portfolio. CBC-GHO's positioning will also be tested by the pace of biotech IPO market recovery, as the pipeline of investee companies seeking exit through public listings is a key return driver.

Synthesized from 1 source.